See also this year's filing and all EDGAR filings for this company.
PDF Report 0001269021_2017_Portola_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001269021, Portola Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 328,928,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,143,000 |
| 3 | remainder_Assets | 8,365,000 |
| 4 | LiabilitiesCurrent | 65,664,000 |
| 5 | LiabilitiesNoncurrent | 2,057,000 |
| 6 | remainder_Liabilities | 83,026,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 58,235,000 |
| 9 | ResearchAndDevelopmentExpense | 246,854,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 36,976,000 |
| 13 | remainder_ComprehensiveNetIncome | -792,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 343,436,000 |
| 1 | Liabilities | 150,747,000 |
| 2 | Expenses | 305,089,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 192,689,000 |
| 5 | NetIncome | -268,113,000 |
| 6 | ComprehensiveNetIncome | -268,509,000 |
| 7 | BaseVar | 418,520,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.613 |
| 9 | EconomicCapitalRatio | 1.98 |
Edgar->Model Mapping
Feature Distribution
